These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 18657898
1. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms. Wu H, Cao Y, Weng D, Xing H, Song X, Zhou J, Xu G, Lu Y, Wang S, Ma D. Cancer Lett; 2008 Nov 28; 271(2):260-71. PubMed ID: 18657898 [Abstract] [Full Text] [Related]
2. [Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms]. Wu HJ, Wu HT, Weng DH, Xing H, Lu YP, Ma D. Zhonghua Fu Chan Ke Za Zhi; 2007 Sep 28; 42(9):612-6. PubMed ID: 17983517 [Abstract] [Full Text] [Related]
5. [Inhibition of mitochondrial Smac release by Akt in chemoresistant ovarian cancer cells]. Yang XK, Wang JD, Wang SY, Zhang YX. Zhonghua Zhong Liu Za Zhi; 2008 Apr 28; 30(4):259-62. PubMed ID: 18788627 [Abstract] [Full Text] [Related]
7. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. Fraser M, Bai T, Tsang BK. Int J Cancer; 2008 Feb 01; 122(3):534-46. PubMed ID: 17918180 [Abstract] [Full Text] [Related]
8. [Relationship between the Akt-regulated direct p53 mitochondrial translocation and the resistance to cisplatin of ovarian cancer cells]. Zhou Y, Wang SY, Yang XK, Wang HM. Zhonghua Zhong Liu Za Zhi; 2011 Feb 01; 33(2):97-100. PubMed ID: 21575475 [Abstract] [Full Text] [Related]
9. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Lee S, Choi EJ, Jin C, Kim DH. Gynecol Oncol; 2005 Apr 01; 97(1):26-34. PubMed ID: 15790433 [Abstract] [Full Text] [Related]
12. Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway. Chen Q, Qin R, Fang Y, Li H. Cell Physiol Biochem; 2015 Apr 01; 36(3):956-65. PubMed ID: 26087719 [Abstract] [Full Text] [Related]
15. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway. Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH. Tumour Biol; 2016 Nov 01; 37(11):15315-15324. PubMed ID: 27699665 [Abstract] [Full Text] [Related]
16. Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer. Xia X, Ma Q, Li X, Ji T, Chen P, Xu H, Li K, Fang Y, Weng D, Weng Y, Liao S, Han Z, Liu R, Zhu T, Wang S, Xu G, Meng L, Zhou J, Ma D. BMC Cancer; 2011 Sep 21; 11():399. PubMed ID: 21933447 [Abstract] [Full Text] [Related]
17. [Effects of PTEN over-expression on phosphatidyl inositol 3-kinase/protein kinase B signal pathway in ovarian epithelial cancer cells]. Zhai YN, Xu LL, Shen Y, Xia H, Shen YF. Zhonghua Fu Chan Ke Za Zhi; 2010 Sep 21; 45(9):682-5. PubMed ID: 21092549 [Abstract] [Full Text] [Related]
20. Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene. Wu H, Wang S, Weng D, Xing H, Song X, Zhu T, Xia X, Weng Y, Xu G, Meng L, Zhou J, Ma D. Cancer Lett; 2008 Nov 28; 271(2):205-14. PubMed ID: 18662848 [Abstract] [Full Text] [Related] Page: [Next] [New Search]